Biotech

All Articles

Vaxcyte climbs on 'spectacular' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what experts named "stunning" period 1/2 records for its 31-valent pneumococcal va...

Recursion's mind ailment trial reveals insufficient proof of efficacy

.Recursion has discovered with an early exam of its tech-enabled method to medicine discovery, discl...

Acepodia, Pfizer click together for chemistry-based tissue treatment

.Call it a case of good chemical make up: Acepodia, a biotech based upon Nobel Champion science, is ...

Praxis epilepsy medicine lowers confiscations in stage 2 trial

.Practice Accuracy Medicines has scored an additional midphase gain in epilepsy this year, with its ...

Three officers surrender as Dyne blog posts blended records for DMD candidate

.After running away a professional grip several years back, Dyne Therapy has uncovered brand-new sta...

Arrowhead fires off period 3 records in uncommon metabolic illness in front of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its own hand in front of a possible face-off along wit...

Pfizer, Valneva present lyme disease shot helpful for second booster

.Pfizer and also Valneva might have regarding 2 even more years to stand by before they create the 1...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Permit's dive into a discussion with Ayla Ellison, Strong Biotech Managing Editor as well as Michel...

New data demonstrate how Bayer's asundexian stopped working to avoid movements

.Bayer suspended the stage 3 trial for its factor XIa prevention asundexian late in 2015 after the m...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own various sclerosis (MS) med tolebrutinib to the FDA, ...